Cloning and sequencing. Cloning and sequencing of the final enriched pool was performed using a previously reported protocol (1). Briefly, the enriched sequences from the final pool (Round S6) were amplified by PCR with unlabeled forward and reverse primers (Supplementary Table S2 , FP and RP) using the same program as described above in 'SELEX procedure'. At the end of the amplification protocol, an additional 30 min extension step was performed at 72 °C to add a poly-A tail. Amplicons were cloned into a plasmid vector and transformed into E. coli cells using the TOPO TA cloning kit (Invitrogen) according to the supplier recommendations. The plasmids from 50 randomly picked colonies were extracted using a PureLink Quick Plasmid Miniprep Kit (Invitrogen) and sequenced via Sanger Sequencing at the Florida International University DNA Core Facility. After removing the sequences of the plasmid and primers, the aptamer sequences were aligned with BioEdit software to determine the consensus sequence.
Isothermal titration calorimetry (ITC).
ITC was performed using a MicroCal ITC200 instrument (Malvern). All ITC experiments were carried out using the following protocol at 23 °C. A solution containing the aptamer (final concentration 20 µM) was prepared in selection buffer (10 mM Tris-HCl, 0.5 mM MgCl2, 20 mM NaCl, pH 7.4) and loaded into the ITC sample cell. We then loaded different concentrations of synthetic cathinone (350 µM (±)-α-PVP, 300 µM (±)-ethylone, 400 µM (±)-butylone, 300 µM (±)-MDPV, 225 µM (-)-MDPV, or 400 µM (+)-MDPV) or interferent (1 mM (±)-amphetamine, (+)-methamphetamine, cocaine, procaine, or (+)-ephedrine) in the same buffer into the syringe and titrated it into the cell, with an initial 0.4 μL purge injection followed by 19 successive 2 μL injections. A spacing of 180 seconds was used between each titration. The heat generated from each titration was recorded, and the binding stoichiometry (N), enthalpy (ΔH), and KD were obtained by fitting the resulting titration curve with a single-site binding model (wherein the aptamer and synthetic cathinone are considered to be the receptor and ligand, respectively) using the MicroCal analysis kit integrated into Origin 7 software. All titrations involving racemic synthetic cathinone mixtures were also fitted with a modified two-site binding model to determine the binding parameters for each enantiomer. This model assumes that a receptor with two ligand-binding sites independently interacts with a ligand. Unlike the single-site binding model, the aptamer in the sample cell is considered as the ligand and the pair of synthetic cathinone enantiomers is considered as a receptor with two discrete binding sites. For example, titration of 300 µM (±)-MDPV -containing 150 µM each of (-)-MDPV and (+)-MDPV -into 20 µM SCA2.1 is treated as titration of 150 µM of a receptor with two independent 'binding sites' into 20 µM of ligand. The binding parameters of the first site (i.e. N1, KD1, ΔH1) reflect the binding of one of the enantiomers to the aptamer, while those for the second site (i.e. N2, KD2, ΔH2) reflect the binding of the other.
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